Related Experiment Video
Updated: Aug 5, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
A Therapeutic Dilemma: Catastrophic ST-Elevation Myocardial Infarction Following Antiplatelet Therapy Interruption in
Behrouz Zarei1, Amirhossein Rezaei Latifi2, Mohammad Salari2
1Department of Cardiology, Faculty of Medicine Hormozgan University of Medical Sciences Bandar Abbas Iran.
Abstract:
Polycythemia vera is associated with a thrombotic-hemorrhagic paradox. We report a 75-year-old woman with recurrent ST-elevation myocardial infarction and stent thrombosis after premature dual antiplatelet therapy interruption. Revascularization was successful, and eptifibatide bridging enabled safe surgery. This case highlights the risks of interruption and the role of bridging therapy.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease III: Interprofessional Care
Myocarditis III: Medical Management
Venous Thrombosis III: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
